Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL622136 | 0.91 | ALDH1A1 (0.64) | ALDH1A1CA2LMNATDP1CYP3A4 | |
| SCHEMBL53705 | 0.86 | — | — | |
| SCHEMBL2381705 | 0.86 | — | — | |
| SCHEMBL16269718 | 0.86 | ALDH1A1 (0.52) | ALDH1A1LMNACYP3A4THRBUSP2 | |
| SCHEMBL1934981 | 0.86 | — | — | |
| Glycerin SCHEMBL27075577 | 0.84 | ALDH1A1 (0.82) | ALDH1A1CA2LMNATDP1CYP3A4 | |
| SCHEMBL31292800 | 0.84 | — | — | |
| SCHEMBL28479835 | 0.84 | — | — | |
| SCHEMBL22572340 | 0.84 | — | — | |
| Glycerin SCHEMBL278378 | 0.84 | LMNA (0.50) | ALDH1A1LMNACYP3A4THRBUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795320-B2 | Grafted polymer and use thereof | BAUSCH + LOMB IRELAND LIMITED (IE) | 2023-10-24 | — | — | US | disclosed |
| US-11732060-B2 | Crosslinked polymeric network and use thereof | BAUSCH & LOMB INCORPORATED (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230257485-A1 | GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2023-08-17 | — | — | US | disclosed |
| US-11673974-B2 | Glycophospholipid polymeric network and use thereof | BAUSCH & LOMB INCORPORATED (US) | 2023-06-13 | — | — | US | disclosed |
| EP-2099294-B1 | COMPOSITIONS | GIVAUDAN SA (CH) | 2013-05-08 | — | — | EP | disclosed |
| US-8377126-B2 | Renewable polymeric lens coating | BAUSCH & LOMB INCORPORATED (US) | 2013-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11673974-B2 | Glycophospholipid polymeric network and use thereof | ALG1, CSGALNACT1, FUT5 | ALDH1A1 3218/4885CA2 3651/4885LMNA 2758/4885 |
| US-11732060-B2 | Crosslinked polymeric network and use thereof | ALG1, CSGALNACT1, CD44 | ALDH1A1 1752/4885CA2 3584/4885LMNA 3262/4885 |
| US-20230257485-A1 | GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF | ALG1, CSGALNACT1, FUT6 | ALDH1A1 4141/4885CA2 2892/4885LMNA 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.